Erythrocyte-bound apolipoprotein B in atherosclerosis and mortality.

about

Erythrocyte-bound apolipoprotein B in atherosclerosis and mortality.

Item

http://www.wikidata.org/entity/Q38987688

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Erythrocyte-bound apolipoprotein B in atherosclerosis and mortality.

@en

type

Item

label

Erythrocyte-bound apolipoprotein B in atherosclerosis and mortality.

@en

prefLabel

Erythrocyte-bound apolipoprotein B in atherosclerosis and mortality.

@en

P1476

Erythrocyte-bound apolipoprotein B in atherosclerosis and mortality.

@en

P2093

Anho H Liem

http://www.w3.org/2001/XMLSchema#string

Boudewijn Klop

http://www.w3.org/2001/XMLSchema#string

Ellen M van der Zwan-van Beek

http://www.w3.org/2001/XMLSchema#string

Erwin Birnie

http://www.w3.org/2001/XMLSchema#string

Gert-Jan M van de Geijn

http://www.w3.org/2001/XMLSchema#string

Manuel Castro Cabezas

http://www.w3.org/2001/XMLSchema#string

Marijke A de Vries

http://www.w3.org/2001/XMLSchema#string

Marjolein van Vliet

http://www.w3.org/2001/XMLSchema#string

Noëlle van der Meulen

http://www.w3.org/2001/XMLSchema#string

Selvetta S van Santen

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?

A catalogue of reporting guidelines for health research.

The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.

Erythrocyte-bound apolipoprotein B in relation to atherosclerosis, serum lipids and ABO blood group.

Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study

Inflammation in atherosclerosis.

Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans.

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Recent progress in understanding apolipoprotein B.

P304

289-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ECI.12728

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wouter W de Herder

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28144944

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis